| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/28/2008 | CN100389755C Compositions and methods for mucosal delivery |
| 05/28/2008 | CN100389753C Oral drop pills with heat-clearing and detoxification function |
| 05/27/2008 | US7378535 Production of furanones |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378490 a cyclic dodecapeptide containing Arg, Asp, Ala, Glu, Ser, Gly, Ala; cyclic peptides serve as antigens for producing a neutralizing antibody capable of neutralizing HIV-1 virus infection via the second receptors called CXCR4 and CCR5 |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378408 Methods of treatment and formulations of cephalosporin |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008059885A1 Gel-like sterilizing/disinfecting composition |
| 05/22/2008 | WO2008059662A1 Retrovirus-infection inhibitor |
| 05/22/2008 | WO2008059367A1 Penem prodrugs |
| 05/22/2008 | WO2008059261A1 Clotrimazol for treating staphylococcal infections |
| 05/22/2008 | WO2008059258A2 Imidazoles for treating multi-drug resistant bacterial infections |
| 05/22/2008 | WO2008059223A2 Process for the synthesis of moxifloxacin hydrochloride |
| 05/22/2008 | WO2008059068A2 Carbonyl-substituted titanocenes |
| 05/22/2008 | WO2008059066A1 New chemokine derivatives of ccl14, synthesis and use as drugs for the treatment of allergic diseases |
| 05/22/2008 | WO2008059046A1 Macrocyclic inhibitors of hepatitis c virus |
| 05/22/2008 | WO2008059014A2 Antituberculosis agents with alkylidene or alkyl side chain |
| 05/22/2008 | WO2008058993A2 Use of alpha ketogluaric acid for the treatment of infection with h. pylori |
| 05/22/2008 | WO2008058897A2 Diphyllin and other lignans as a medicament for v-atpase mediated disease |
| 05/22/2008 | WO2008058766A1 Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection |
| 05/22/2008 | WO2008058694A1 Extraction method for the classified extraction and separation of vegetable component materials, and the application thereof |
| 05/22/2008 | WO2008058547A2 Alpha-lactalbumin composition |
| 05/22/2008 | WO2008058451A2 Ultrasound microbubble mediated genes delivery system |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058396A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | WO2008058393A1 Thiophene analogues for the treatment or prevention of flavivirus infections |
| 05/22/2008 | WO2008058369A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | WO2008040516A3 Microbiological composition and use thereof |
| 05/22/2008 | WO2008036420A3 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 05/22/2008 | WO2008027000A3 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 05/22/2008 | WO2008026999A3 Candidates against infection |
| 05/22/2008 | WO2008003149A3 Substituted pteridines for the treatment and prevention of viral infections |
| 05/22/2008 | WO2008000466A3 Use of an antimicrobial hardening alginate material for the topical treatment of wounds and inflammations in human, dental, and veterinary medicine and for cosmetic purposes |
| 05/22/2008 | WO2007117264A3 Compositions and methods for production of immunoglobulins |
| 05/22/2008 | WO2007109747A3 Methods and compositions for antagonism of rage |
| 05/22/2008 | US20080119568 Gastrointestinal Absorption Enhancer Mediated By Proton-Coupled Transporter and Its Preparing Method |
| 05/22/2008 | US20080119567 Geranium oil and extracts from roots of Sophora; H. pylori infection; citronellol; sodium/potassium ATPase inhibitors; cardiovascular disorders; gastric ulcers |
| 05/22/2008 | US20080119545 Method for preventing and treating avian influenza in human |
| 05/22/2008 | US20080119542 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 05/22/2008 | US20080119541 Novel genes encoding a nystatin polyketide synthase and their manipulation and utility |
| 05/22/2008 | US20080119533 New class of antibiotic with potent antibacterial activity against even methicillin resistant Staphylcoccus aureus (MRSA); 3-methylthio-4-phenyl-5-methoxyacetyl-oxazolidin-2-one for example |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119513 To treat osteoarthritis; matrix metalloproteinases-13 inhibitors |
| 05/22/2008 | US20080119509 Nontoxic; asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), eosinophilic granuloma, psoriasis |
| 05/22/2008 | US20080119508 Multi-Route Administration Of Immune Response Modifier Compounds |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |
| 05/22/2008 | US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/22/2008 | US20080119490 Viral Polymerase Inhibitors |
| 05/22/2008 | US20080119483 Synergistic combination of lipid synthesis inhibitors; no side effects; itraconazole or ketaconazole |
| 05/22/2008 | US20080119478 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria |
| 05/22/2008 | US20080119461 N-(4,6-dimethyl-2-pyridinyl)-L-valyl-(4R) N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)oxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 05/22/2008 | US20080119450 Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 05/22/2008 | US20080119419 Bifunctional heterocyclic compounds and methods of making and using same |
| 05/22/2008 | US20080119405 Fowlicidins and Methods of Their Use |
| 05/22/2008 | US20080119395 Novel Depsipeptides and Process for Preparing Same |
| 05/22/2008 | US20080118580 plant extracts contains terpenes, plant extracts, and cinnamic acid, use as fungicide for textile treatment; fucoidine, anethol, geraniol, farnesol or farnesol acid; low concentrations and reduce side-effects |
| 05/22/2008 | US20080118535 Surface protein of Neisseria bacteria |
| 05/22/2008 | US20080118533 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 05/22/2008 | US20080118527 Vaccine comprising hepatitis b viral antigen and hemophilus influenza b protein for use in prevention and treament of viral disease |
| 05/22/2008 | US20080118516 Using natural killer cell receptor modulators as therapeutic tools in prevention and treatment of viral diseases |
| 05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | US20080118473 Methods of treating a respiratory condition comprising probiotic treatment |
| 05/22/2008 | CA2670260A1 Thiophene analogues for the treatment or prevention of flavivirus infections |
| 05/22/2008 | CA2669763A1 Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection |
| 05/22/2008 | CA2669594A1 Clotrimazol for treating staphylococcal infections |
| 05/22/2008 | CA2669591A1 Treatment of multi-drug resistant bacterial infections |
| 05/22/2008 | CA2669485A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | CA2669427A1 Process for the synthesis of moxifloxacin hydrochloride |
| 05/22/2008 | CA2669357A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | CA2669345A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | CA2669310A1 Hepatitis c virus inhibitors |
| 05/22/2008 | CA2661338A1 Macrocyclic inhibitors of hepatitis c virus |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1923071A1 Equine herpesvirus vaccine |
| 05/21/2008 | EP1923063A2 Compositions and methods for combination antiviral therapy |
| 05/21/2008 | EP1922333A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/21/2008 | EP1922317A2 Amide and carbamate derivatives of n-{2-ý4-amino-2- (ethoxymethyl)-1h-imidazoý4,5-c¨quinolin-1-yl¨-1,1-dimethylethyl}methanesulfonamide and methods |
| 05/21/2008 | EP1765755A4 Regulators of bacterial signalling pathways |
| 05/21/2008 | EP1581238B1 Improvements in or relating to immune functions |
| 05/21/2008 | EP1467753B1 Recombinant herpesvirus of turkeys and use thereof |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | EP1144001B1 Inactivated influenza virus vaccine for nasal or oral administration |
| 05/21/2008 | EP1096952B1 Polysaccharide vaccine for staphylococcal infections |
| 05/21/2008 | EP1078002B1 Peptide antiangiogenic drugs |
| 05/21/2008 | EP0904395B1 Herpes simplex virus strains |
| 05/21/2008 | EP0781138B1 Lipid analogs for treating viral infections |